The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase l and randomized phase ll trial of radium-223 dichloride, peposertib, and avelumab in advanced metastatic castrate-resistant prostate cancer (mCRPC): Phase l results.
 
Hiram Gay
No Relationships to Disclose
 
Ningying Wu
No Relationships to Disclose
 
Jingqin Luo
No Relationships to Disclose
 
Russ Kuker
Stock and Other Ownership Interests - GE Healthcare, Eli Lilly
Research Funding - ADC Therapeutics (Inst)
 
Elisabeth Heath
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Janssen; Johnson & Johnson/Janssen; Sanofi; Seagen
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; EMD Serono; Gilead Sciences; Novartis; Sanofi
Speakers' Bureau - Sanofi
Research Funding - Arvinas (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); BioXCel therapeutics (Inst); Bristol-Myers Squibb (Inst); Calibr (Inst); Calithera Biosciences (Inst); Caris Life Sciences (Inst); Corcept Therapeutics (Inst); Corvus Pharmaceuticals (Inst); Daiichi Sankyo Inc. (Inst); Eisai (Inst); Exelixis (Inst); Five Prime Therapeutics (Inst); Fortis (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Harpoon therapeutics (Inst); Infinity Pharmaceuticals (Inst); ITeos Therapeutics (Inst); Janssen Research & Development (Inst); Merck (Inst); Merck Sharp & Dohme (Inst); Mirati Therapeutics (Inst); Modra Pharmaceuticals (Inst); Novartis (Inst); Oncolys BioPharma (Inst); Peloton Therapeutics (Inst); Pfizer (Inst); Pharmacyclics (Inst); POINT Biopharma (Inst); Roche (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Sanofi
Other Relationship - Caris Centers of Excellence
 
Savita Dandapani
Research Funding - Bayer helps sponsor my investigator initiated protocol
 
Zin Myint
Research Funding - Merck (Inst)
 
Kevin Courtney
Consulting or Advisory Role - Novartis
Research Funding - Amgen (Inst); Astellas Pharma (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); AstraZeneca (Inst); Celgene/Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); DualityBio (Inst); Exelixis (Inst); Harpoon therapeutics (Inst); Janssen Research & Development (Inst); Lilly (Inst); Myovant Sciences (Inst); Novartis (Inst); Pfizer (Inst); Stemline Therapeutics (Inst); Surface Oncology (Inst)
Patents, Royalties, Other Intellectual Property - My spouse receives patent royalties from Athena Diagnostics, Inc. (I)
 
Anishka D'souza
No Relationships to Disclose
 
Lindsey Mayer
Research Funding - Novartis, Blue Earth Therapeutics, RayzeBio, Janssen, Merck (Inst)
 
Collin Welch
Research Funding - Merck; Janssen; Novartis; Rayze Bio; Blue Earth Therapeutics (Inst)
 
Tanner Johanns
No Relationships to Disclose
 
Lorraine Pelosof
No Relationships to Disclose
 
Steven Gore
No Relationships to Disclose
 
Nina Lukinova
No Relationships to Disclose
 
Jeff Michalski
Leadership - American Society of Therapeutic Radiation Oncology
Travel, Accommodations, Expenses - American Society of Therapeutic Radiation Oncology
 
Nataliya Mar
Consulting or Advisory Role - AVEO; EMD Serono; Exelixis; Pfizer
Speakers' Bureau - Eisai; Merck
Research Funding - Gilead Sciences